LifePoint Health, Inc. (LPNT) Earns “Hold” Rating from KeyCorp

KeyCorp reiterated their hold rating on shares of LifePoint Health, Inc. (NASDAQ:LPNT) in a research report report published on Sunday, October 29th. KeyCorp also issued estimates for LifePoint Health’s Q4 2017 earnings at $0.88 EPS, FY2017 earnings at $3.70 EPS, FY2018 earnings at $4.17 EPS and FY2019 earnings at $4.70 EPS.

LPNT has been the topic of several other reports. SunTrust Banks, Inc. set a $60.00 target price on LifePoint Health and gave the stock a hold rating in a research report on Thursday, October 12th. BMO Capital Markets assumed coverage on LifePoint Health in a report on Monday, October 16th. They set a market perform rating and a $59.00 price objective on the stock. ValuEngine raised LifePoint Health from a hold rating to a buy rating in a report on Thursday, August 17th. BidaskClub lowered LifePoint Health from a hold rating to a sell rating in a report on Tuesday, August 1st. Finally, Zacks Investment Research upgraded LifePoint Health from a sell rating to a hold rating in a research note on Monday, August 21st. Two analysts have rated the stock with a sell rating, twelve have issued a hold rating and four have assigned a buy rating to the company’s stock. The company has a consensus rating of Hold and a consensus target price of $60.23.

Shares of LifePoint Health (NASDAQ:LPNT) opened at $43.50 on Friday. The company has a market capitalization of $1,754.00, a price-to-earnings ratio of 11.35, a PEG ratio of 1.16 and a beta of 0.68. LifePoint Health has a fifty-two week low of $43.05 and a fifty-two week high of $70.95. The company has a current ratio of 1.85, a quick ratio of 1.65 and a debt-to-equity ratio of 1.24.

LifePoint Health (NASDAQ:LPNT) last posted its quarterly earnings results on Friday, October 27th. The company reported $0.80 earnings per share for the quarter, missing the consensus estimate of $0.95 by ($0.15). The business had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.60 billion. LifePoint Health had a net margin of 2.45% and a return on equity of 7.01%. The firm’s quarterly revenue was down .7% on a year-over-year basis. During the same period in the previous year, the firm posted $0.94 earnings per share. sell-side analysts anticipate that LifePoint Health will post 3.65 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: This story was originally published by Week Herald and is owned by of Week Herald. If you are reading this story on another domain, it was illegally copied and reposted in violation of US & international copyright law. The legal version of this story can be read at https://weekherald.com/2017/11/15/lifepoint-health-inc-lpnt-receives-hold-rating-from-keycorp.html.

LifePoint Health announced that its board has authorized a share buyback plan on Friday, October 27th that allows the company to buyback $200.00 million in shares. This buyback authorization allows the company to repurchase shares of its stock through open market purchases. Shares buyback plans are often a sign that the company’s board of directors believes its stock is undervalued.

A number of hedge funds have recently added to or reduced their stakes in LPNT. Principal Financial Group Inc. increased its holdings in LifePoint Health by 1.9% during the 1st quarter. Principal Financial Group Inc. now owns 163,064 shares of the company’s stock valued at $10,681,000 after purchasing an additional 2,992 shares in the last quarter. Legal & General Group Plc increased its stake in shares of LifePoint Health by 30.4% in the 1st quarter. Legal & General Group Plc now owns 57,028 shares of the company’s stock valued at $3,736,000 after buying an additional 13,304 shares during the period. Thrivent Financial For Lutherans increased its stake in shares of LifePoint Health by 9.2% in the 1st quarter. Thrivent Financial For Lutherans now owns 7,570 shares of the company’s stock valued at $496,000 after buying an additional 640 shares during the period. Vanguard Group Inc. increased its stake in shares of LifePoint Health by 3.8% in the 1st quarter. Vanguard Group Inc. now owns 3,266,963 shares of the company’s stock valued at $213,986,000 after buying an additional 120,201 shares during the period. Finally, Geode Capital Management LLC increased its stake in shares of LifePoint Health by 4.9% in the 1st quarter. Geode Capital Management LLC now owns 330,096 shares of the company’s stock valued at $21,620,000 after buying an additional 15,276 shares during the period. 99.18% of the stock is owned by hedge funds and other institutional investors.

About LifePoint Health

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Analyst Recommendations for LifePoint Health (NASDAQ:LPNT)

Receive News & Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply